Literature DB >> 3096266

Biological half-life, organ distribution and excretion of 125-I-labelled toxic peptide from the blue-green alga Microcystis aeruginosa.

I R Falconer, T Buckley, M T Runnegar.   

Abstract

M. aeruginosa is a bloom-forming cyanobacterium which is common in fresh-water lakes. It contains a potent hepatotoxin which when purified has been shown to be a heptapeptide of molecular weight 1019. The toxin was iodinated with 125I using the lactoperoxidase method, the labelled toxin administered intravenously to adult female rats and the half-life and organ distribution measured. The blood half-life after redistribution into extracellular pools was 42 min. The liver and kidneys showed accumulation of 21.7 +/- 1.1 and 5.6 +/- 0.2% of the dose respectively after 30 min. Little accumulation was observed in other organs and tissues. Small-intestinal contents and urine contained 9.4 +/- 6.1 and 2.9 +/- 1.2% of the dose respectively after 120 min. It was concluded that the liver is the main target organ for both accumulation and excretion of the toxin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096266

Source DB:  PubMed          Journal:  Aust J Biol Sci        ISSN: 0004-9417


  4 in total

Review 1.  Cyanobacterial toxins: removal during drinking water treatment, and human risk assessment.

Authors:  B C Hitzfeld; S J Höger; D R Dietrich
Journal:  Environ Health Perspect       Date:  2000-03       Impact factor: 9.031

Review 2.  Microcystin Toxicokinetics, Molecular Toxicology, and Pathophysiology in Preclinical Rodent Models and Humans.

Authors:  Tarana Arman; John D Clarke
Journal:  Toxins (Basel)       Date:  2021-07-29       Impact factor: 4.546

3.  Cyanobacterial toxin degrading bacteria: who are they?

Authors:  Konstantinos Ar Kormas; Despoina S Lymperopoulou
Journal:  Biomed Res Int       Date:  2013-06-06       Impact factor: 3.411

4.  Sublethal microcystin exposure and biochemical outcomes among hemodialysis patients.

Authors:  Elizabeth D Hilborn; Raquel M Soares; Jerome C Servaites; Alvima G Delgado; Valéria F Magalhães; Wayne W Carmichael; Sandra M F O Azevedo
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.